Healthcare provider profile · identity verified

Mark Franklin Moore, M.D.

Internal Medicine · DUBUQUE, IA · NPI 1922052786

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	844	221
Amlodipine Besylate	Amlodipine Besylate	680	190
Losartan Potassium	Losartan Potassium	605	166
Levothyroxine Sodium	Levothyroxine Sodium	507	108
Omeprazole	Omeprazole	443	121
Simvastatin	Simvastatin	442	123
Rosuvastatin Calcium	Rosuvastatin Calcium	412	114
Furosemide	Furosemide	371	81
Lisinopril	Lisinopril	349	95
Metoprolol Tartrate	Metoprolol Tartrate	308	71
Hydrochlorothiazide	Hydrochlorothiazide	306	83
Metoprolol Succinate	Metoprolol Succinate	299	85
Potassium Chloride	Potassium Chloride	294	62
Atenolol	Atenolol	276	71
Pantoprazole Sodium	Pantoprazole Sodium	251	57
Alprazolam	Alprazolam	228	61
Tamsulosin Hcl	Tamsulosin Hcl	217	60
Eliquis	Apixaban	215	38
Pravastatin Sodium	Pravastatin Sodium	211	53
Gabapentin	Gabapentin	179	33
Alendronate Sodium	Alendronate Sodium	177	51
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	166	48
Clopidogrel	Clopidogrel Bisulfate	165	36
Metformin Hcl	Metformin Hcl	164	45
Mirtazapine	Mirtazapine	146	32
Sertraline Hcl	Sertraline Hcl	125	20
Donepezil Hcl	Donepezil Hcl	123	27
Escitalopram Oxalate	Escitalopram Oxalate	123	29
Allopurinol	Allopurinol	119	32
Lorazepam	Lorazepam	101	18
Warfarin Sodium	Warfarin Sodium	95	suppressed
Ezetimibe	Ezetimibe	94	28
Fluoxetine Hcl	Fluoxetine Hcl	93	20
Citalopram Hbr	Citalopram Hydrobromide	83	26
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	79	20
Enalapril Maleate	Enalapril Maleate	75	18
Duloxetine Hcl	Duloxetine Hcl	71	17
Memantine Hcl	Memantine Hcl	71	suppressed
Myrbetriq	Mirabegron	64	suppressed
Glimepiride	Glimepiride	63	20
Trazodone Hcl	Trazodone Hcl	59	suppressed
Famotidine	Famotidine	57	11
Fluticasone Propionate	Fluticasone Propionate	55	16
Lovastatin	Lovastatin	52	15
Metformin Hcl Er	Metformin Hcl	51	15
Ondansetron Hcl	Ondansetron Hcl	49	13
Prednisone	Prednisone	49	29
Levetiracetam	Levetiracetam	48	suppressed
Tramadol Hcl	Tramadol Hcl	47	15
Spironolactone	Spironolactone	45	12
Quetiapine Fumarate	Quetiapine Fumarate	44	suppressed
Carvedilol	Carvedilol	42	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	41	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	40	11
Zolpidem Tartrate	Zolpidem Tartrate	40	suppressed
Finasteride	Finasteride	37	11
Latanoprost	Latanoprost	37	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	35	34
Albuterol Sulfate Hfa	Albuterol Sulfate	32	17
Meloxicam	Meloxicam	32	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	31	29
Cephalexin	Cephalexin	30	17
Risperidone	Risperidone	30	suppressed
Nitroglycerin	Nitroglycerin	29	18
Scopolamine	Scopolamine	29	suppressed
Divalproex Sodium Er	Divalproex Sodium	28	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	28	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Amoxicillin	Amoxicillin	26	12
Xarelto	Rivaroxaban	26	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Benazepril Hcl	Benazepril Hcl	24	suppressed
Nifedipine Er	Nifedipine	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Clonazepam	Clonazepam	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	15
Fenofibrate	Fenofibrate	22	suppressed
Midodrine Hcl	Midodrine Hcl	22	suppressed
Sucralfate	Sucralfate	21	suppressed
Temazepam	Temazepam	21	suppressed
Estradiol	Estradiol	20	suppressed
Pentoxifylline	Pentoxifylline	20	suppressed
Terazosin Hcl	Terazosin Hcl	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Gemfibrozil	Gemfibrozil	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	16
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Baclofen	Baclofen	17	suppressed
Cilostazol	Cilostazol	17	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Digoxin	Digoxin	16	suppressed
Methylprednisolone	Methylprednisolone	16	15
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Benztropine Mesylate	Benztropine Mesylate	15	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	15	suppressed
Labetalol Hcl	Labetalol Hcl	15	suppressed
Lactulose	Lactulose	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Primidone	Primidone	14	suppressed
Azithromycin	Azithromycin	13	13
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Nystatin	Nystatin	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Ursodiol	Ursodiol	13	suppressed
Valsartan	Valsartan	13	suppressed
Anastrozole	Anastrozole	12	suppressed
Celecoxib	Celecoxib	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	11
Clonidine	Clonidine	12	suppressed
Fluconazole	Fluconazole	12	11
Hydroxyurea	Hydroxyurea	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Metolazone	Metolazone	12	suppressed
Safetyglide Insulin Syringe	Syringe,needle,insuln,sf 0.5ml	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Lovaza	Omega-3 Acid Ethyl Esters	11	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error